Cingulate (CING) vs MAIA Biotechnology (MAIA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cingulate (CING) has outperformed MAIA Biotechnology (MAIA) over the past year, gaining 17.3% versus a loss of 34.1%. MAIA Biotechnology is the larger company by market cap ($72.9 million vs $70.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CING | MAIA |
|---|---|---|
| Share price | $4.87 | $1.18 |
| Market cap | $70.82M | $72.86M |
| 1-day change | -0.41% | -0.84% |
| YTD return | +12.21% | -22.88% |
| 1-year return | +17.35% | -34.08% |
| Forward P/E | — | 1.06 |
| EPS (TTM) | $-3.51 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.89 | $3.19 |
| 52-week low | $3.16 | $0.87 |
| Distance from 52-week high | -59.04% | -63.01% |
| Average volume | 150.39K | 528.51K |
| Shares outstanding | 14.54M | 61.74M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CING has outperformed MAIA by 51.4 percentage points over the past year.
CING vs MAIA FAQ
Which is bigger, Cingulate or MAIA Biotechnology?
MAIA Biotechnology (MAIA) is larger, with a market capitalization of $72.86M compared with $70.82M for Cingulate (CING).
Which stock has performed better over the past year, CING or MAIA?
CING returned +17.35% over the past 12 months, compared with -34.08% for MAIA (price return, excluding dividends). Past performance does not predict future results.
Are Cingulate and MAIA Biotechnology in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.